Encouraging results for new squamous cell cancer treatment
Alpha radiation technology passes first hurdle, zapping nearly 80% of solid tumors in clinical trial.
Alpha radiation technology passes first hurdle, zapping nearly 80% of solid tumors in clinical trial.
Now going into clinical trials for specific types of cancer, Alpha Tau’s technology shows potential for treating any solid tumor.